| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) S Miyakis, MD Lockshin, T Atsumi, DW Branch, RL Brey, R Cervera, ... Journal of thrombosis and haemostasis 4 (2), 295-306, 2006 | 8328 | 2006 |
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients R Cervera, JC Piette, J Font, MA Khamashta, Y Shoenfeld, MT Camps, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2002 | 2560 | 2002 |
| Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients R Cervera, MA Khamashta, J Font, GD Sebastiani, A Gil, P Lavilla, ... Medicine 82 (5), 299-308, 2003 | 1773 | 2003 |
| A phase III, randomized, placebo‐controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus R Furie, M Petri, O Zamani, R Cervera, DJ Wallace, D Tegzová, ... Arthritis & Rheumatism 63 (12), 3918-3930, 2011 | 1707 | 2011 |
| Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients R Cervera, MA Khamashta, J Font, GD SEBASTIANI, A Gil, P Lavilla, ... Medicine 72 (2), 113-124, 1993 | 1343 | 1993 |
| Immunosuppressive therapy in lupus nephritis: the Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ER Garrido, ... Arthritis & Rheumatism 46 (8), 2121-2131, 2002 | 1302 | 2002 |
| Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of … GK Bertsias, M Tektonidou, Z Amoura, M Aringer, I Bajema, JHM Berden, ... Annals of the rheumatic diseases 71 (11), 1771-1782, 2012 | 1227 | 2012 |
| EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including … GK Bertsias, JPA Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, ... Annals of the rheumatic diseases 67 (2), 195-205, 2008 | 1028 | 2008 |
| US or CT for Diagnosis of Appendicitis in Children and Adults? A Meta-Analysis1 AS Doria, R Moineddin, CJ Kellenberger, M Epelman, J Beyene, S Schuh, ... Radiology 241 (1), 83-94, 2006 | 886 | 2006 |
| EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for … GK Bertsias, JPA Ioannidis, M Aringer, E Bollen, S Bombardieri, IN Bruce, ... Annals of the rheumatic diseases 69 (12), 2074-2082, 2010 | 866 | 2010 |
| EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and … L Andreoli, GK Bertsias, N Agmon-Levin, S Brown, R Cervera, ... Annals of the rheumatic diseases 76 (3), 476-485, 2017 | 826 | 2017 |
| Treat-to-target in systemic lupus erythematosus: recommendations from an international task force RF Van Vollenhoven, M Mosca, G Bertsias, D Isenberg, A Kuhn, ... Annals of the rheumatic diseases 73 (6), 958-967, 2014 | 795 | 2014 |
| Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients R Cervera, R Serrano, GJ Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, ... Annals of the rheumatic diseases 74 (6), 1011-1018, 2015 | 759 | 2015 |
| Accelerated atherosclerosis in autoimmune rheumatic diseases Y Shoenfeld, R Gerli, A Doria, E Matsuura, MM Cerinic, N Ronda, LJ Jara, ... Circulation 112 (21), 3337-3347, 2005 | 759 | 2005 |
| Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients RA Asherson, R Cervera, JC Piette, J Font, JT Lie, A Burcoglu, K Lim, ... Medicine 77 (3), 195-207, 1998 | 698 | 1998 |
| Pathogenesis of antiphospholipid syndrome: understanding the antibodies PL Meroni, MO Borghi, E Raschi, F Tedesco Nature Reviews Rheumatology 7 (6), 330-339, 2011 | 684 | 2011 |
| International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies N Agmon-Levin, J Damoiseaux, C Kallenberg, U Sack, T Witte, M Herold, ... Annals of the rheumatic diseases 73 (1), 17-23, 2014 | 682 | 2014 |
| Anti-inflammatory and immunosuppressive drugs and reproduction M Østensen, M Khamashta, M Lockshin, A Parke, A Brucato, H Carp, ... Arthritis research & therapy 8, 1-19, 2006 | 675 | 2006 |
| Anti-inflammatory and immunosuppressive drugs and reproduction M Østensen, M Khamashta, M Lockshin, A Parke, A Brucato, H Carp, ... Arthritis research & therapy 8, 1-19, 2006 | 675 | 2006 |
| Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients JL Vianna, MA Khamashta, J Ordi-Ros, J Font, R Cervera, A Lopez-Soto, ... The American journal of medicine 96 (1), 3-9, 1994 | 649 | 1994 |
